TITLE

Asthma: clinical assessment

PUB. DATE
December 2004
SOURCE
Thorax;Dec2004 Supplement, Vol. 59, p50
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents some papers related to clinical assessment of asthma. There is currently great interest in developing non-invasive measures of airway inflammation in asthma. Proposed markers of airway inflammation and or oxidative stress in asthma include the exhaled gases, nitric oxide (NO) and carbon monoxide, and exhaled breath condensate pH and nitrite levels. 17 asthmatic subjects were studied during an exacerbation (defined as a clinical deterioration in asthma symptoms warranting treatment with oral corticosteroids). Comparisons were made against serial peak expiratory flow rates(PEFR). There was a significant increase in PEFR over time, reflecting a clinical improvement.
ACCESSION #
17564525

 

Related Articles

  • Daily corticosteroids were not better than as-needed corticosteroids in mild persistent asthma.  // ACP Journal Club;Nov/Dec2005, Vol. 143 Issue 3, p60 

    This article presents information on a clinical study according to which daily corticosteroids were not better than as-needed corticosteroids in mild persistent asthma. This study explored that in patients with mild persistent asthma, how does intermittent, short-course corticosteroid treatment...

  • Is there more than one inflammatory phenotype is asthma? O'Donnell, R. A.; Frew, A. J. // Thorax;Jul2002, Vol. 57 Issue 7, p566 

    The article discusses whether there is more than one inflammatory phenotype in asthma. But there are some problems in asthma investigations. Most asthmatic patients recruited to these studies either had severe disease or were on some form of corticosteroid therapy, raising concerns about...

  • Treatment Comparison of Budesonide/ Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged ≥16 Years with Asthma: Post Hoc Analysis of a Randomized, Double-Blind Study. Kuna, Piotr // Clinical Drug Investigation;2010, Vol. 30 Issue 9, p565 

    Background: Three fixed maintenance-dose inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) combinations for the treatment of asthma are currently available: salmeterol/fluticasone propionate (Seretide™/Advair™/ Adoair™) budesonide/formoterol (Symbicort®) and...

  • Biopharmaceutical Therapeutics for Asthma Remodeling. Das, A. M.; Griswold, D. E.; Torphy, T. J.; Li, L. // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3233 

    Current asthma therapy is aimed at controlling disease symptoms. A subset of asthma patients remains symptomatic despite optimal therapy indicating that an unmet medical need exists for these patients. Innovative therapeutics are needed to treat the unmet need in asthma and biopharmaceutical...

  • Mild persistent asthma and inhaled corticosteroids: is daily therapy really necessary? Bauchner, Howard // Archives of Disease in Childhood;Oct2005, Vol. 90 Issue 10, p1094 

    This article cites a study on the treatment of mild persistent asthma, which was published in the May 6, 2005 issue of the "Journal Watch Pediatrics and Adolescent Medicine." In this double-blind trial, researchers randomized 225 adults with mild persistent asthma to receive twice-daily inhaled...

  • Magnesium and Outcomes in Children with Acute Asthma. Sadovsky, Richard // American Family Physician;6/15/2001, Vol. 63 Issue 12, p2441 

    Presents information on a study by R.J. Scarfone and others that studied the early administration of magnesium to moderately to severely ill children with asthma in a randomized, double-blind, placebo-controlled clinical trial. Description of the study and its results; Conclusion that among a...

  • COMMENTARY: Adults who require inhaled corticosteroids benefits from a moderate starting dose. Thien, Frank // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p72 

    iThe article presents a commentary on the study, which concluded that adults who require inhaled corticosteroids benefits from a moderate starting dose. Airway inflammation is the key pathologic feature of asthma, and ICSs remain the most effective anti-inflammatory medication and the...

  • Breathing life into asthma research. Sayburn, Anna // Update;5/19/2005, Vol. 70 Issue 5, p5 

    This article discusses about the papers on asthma. After years in which little seemed to change, the past month has seen two new research papers that offer different ways of thinking about the disease. It has been accepted in the Great Britain that regular use of inhaled corticosteroids is the...

  • Analysis. Summerton, Nick // Update;5/19/2005, Vol. 70 Issue 5, p26 

    This article presents a study to find out whether intermittent as-needed corticosteroid treatment for mild persistent asthma equivalent to regular daily treatment. Treatment with daily or intermittent corticosteroid therapy in a six-centre randomised controlled trial was conducted. After...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics